How antibody sugar patterns relate to Alzheimer's disease

Deciphering the IgG glycosylation code of Alzheimer's Disease

NIH-funded research Emory University · NIH-11308247

Looking at whether sugar tags on antibodies are linked to Alzheimer's disease in people with the condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEmory University NIH-funded
Lab location1 site (Atlanta, United States)
Project IDNIH-11308247 on NIH RePORTER

What this research studies

We will examine the sugar molecules attached to IgG antibodies using blood samples from people with Alzheimer's and compare them to samples from people without dementia. The team will use lab methods that keep sugars attached to the antibody so they can map which exact sugar patterns appear on each antibody molecule. Researchers will compare these patterns with disease features and progression to see if specific antibody sugar signatures match symptoms or decline. The goal is to find immune-related markers that could help guide diagnosis or future treatments.

Who could benefit from this research

Good fit: Adults diagnosed with Alzheimer's disease or related dementia who can provide blood samples and medical history are the best candidates.

Not a fit: People without Alzheimer's or those unable or unwilling to give blood samples are unlikely to directly benefit from participating.

Why it matters

Potential benefit: If successful, this work could point to blood-based markers or immune-targeted approaches that help diagnose or treat Alzheimer's earlier.

How similar studies have performed: Prior studies have linked antibody glycosylation to Alzheimer's and other diseases, but this project applies newer methods to map glycan patterns more precisely and is partly novel.

Where this research is happening

Atlanta, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer disease treatmentAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.